According to Nectar Lifesciences
's latest financial reports the company has a price-to-book ratio of 0.7356.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.6752 | 33.17% |
2022-12-31 | 0.5070 | -10.14% |
2021-12-31 | 0.5642 | 15.54% |
2020-12-31 | 0.4883 | 103.36% |
2019-12-31 | 0.2401 |